JSNM/JSNMT2018

Session information

[JSMN]Radiopharmaceutical:Quality Control

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » [JSMN]Digital Poster (Oral)

Radiopharmaceutical:Quality Control

Thu. Nov 15, 2018 3:15 PM - 4:15 PM Digital Poster (Exhibition Hall 1F Booth2)

Chair:Kentaro Hatano (Department of Applied Molecular Imaging, Faculty of Medicine, University of Tsukuba, )

Jun Toyohara1, Tetsuro Tago1, Nicola A Colabufo2, Gert Luurtsema3 (1.Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan, 2.Dipartimento di Farmacia-Scienze del Farmaco, Universita degli Studi di Bari, Italy, 3.Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, The Netherlands)

Toshihiro Sakai1,2, Yasukazu Kanai3, Toshimitsu Watanabe4, Yoichiro Ohta2,5, Shoji Yamanaka6, Sadahiro Naka7, Tomohiro Yoshikawa2,5, Yoshihide Hattori2, Osamu Inoue1, Mitsunori Kirihata2, Jun Hatazawa7 (1.Hanwa Intelligent Medical Center, Osaka, Japan, 2.Research Center for Boron Neutron Capture Therapy, Osaka Prefecture University, Osaka, Japan, 3.Kansai BNCT Medical Center, Osaka Medical College, Osaka, Japan, 4.Sumitomo Heavy Industries Ltd, Tokyo, Japan, 5.Stella Pharma Corporation, Osaka, Japan, 6.SHI Accelerator Service Ltd, Tokyo, Japan, 7.Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan)

Natsuki Honda1, Yasutake Ishikawa2, Tomohiko Aso2, Kanyu Ihara2, Masakazu Yamaguchi1, Kenichi Nakazawa3, Yoshiaki Ito4, Toshimitsu Watanabe5, Yoji Naganuma6, Hiroki Hashimoto7, Atsuo Waki8 (1.National Cancer Center Hospital,Tokyo,Japan, 2.National Cancer Center Hospital,Tokyo,Japan, 3.DALTON CORPORATION Clean air device promotion Division,Tokyo,Japan, 4.Santasalo & Steri-Pro Solution Corporation,Nagoya,Japan, 5.Sumitomo Heavy Industries,Ltd.,Ehime,Japan, 6.Kankyo Eisei Yakuhin,Inc.,Osaka,Japan, 7.Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institute of Quantum Science and Technology,Chiba,Japan, 8.Quality Assurance and Audit Office, National Institute of Radiological Sciences, National Institute of Quantum Science and Technology,Chiba,Japan)

Ching-Hung Chiu1, Ya-Yao Huang1, Ta-kai Chou2, Ching-Huang Lo4, Kun-Lin Tsai5, Ji-Gang Chen4, Sheng-Chieh Chan5, Chia-Ling Tsai1, Chuang-Hsin Chiu3, Ruoh-Fen Yen1,6 (1.PET Center, Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan (R.O.C), 2.PET Center, Department of Nuclear Medicine, Tri-Service General Hospital, National Defense Medical Center, 3.Department of Nuclear Medicine, Tri-Service General Hospital, National Defense Medical Center, 4.Cyclotron center, Shin Kong Wu Ho-Su Memorial Hospital, 5.Department of Nuclear Medicine, Linkou Chang Gung Memorial Hospital, 6.Molecular Imaging Center, National Taiwan University)

Yoshihiro Takasuga1, Shogo Wada2, Hiromi Shiraishi3, Yoshifusa Sadamura1, Kazuko Iwakuma4, Atsuo Waki4 (1.FUJIFILM Wako Pure Chemical Corporation Life Science Research Laboratories, Amagasaki, Japan, 2.FUJIFILM Wako Pure Chemical Corporation Life Science Reagent Development Depertment, Osaka, Japan, 3.FUJIFILM Wako Pure Chemical Corporation Scientific Instruments Sales Support Department, 4.Quality Assurance and Audit Office, National Institute of Radiological Sciences, National Institute of Quantum Science and Technology, Chiba, Japan)